At-Home Tests May Predict Dementia Risk
Early Signals of Cognitive Change
Researchers are exploring new ways to identify people at risk of dementia. A study from the University of Exeter suggests a home-based blood test and online cognitive assessment could be effective. The findings, published recently, offer a potential early detection method. This could allow for earlier interventions and support.
The study focused on identifying specific proteins in blood samples. These proteins are linked to the development of dementia. Researchers analyzed blood taken from a finger prick, sent through the mail. This was combined with results from online brain tests completed by participants. The combination showed promise in predicting future dementia risk.
Currently, diagnosing dementia often happens after noticeable symptoms appear. This means crucial time for potential treatment or lifestyle changes may be lost. The Exeter team aimed to find a way to identify risk factors much earlier. They believe detecting these protein levels, alongside cognitive performance, could be key. The research involved analyzing levels of specific proteins associated with neurodegeneration.
Could This Slow Disease Progression?
The study revealed a correlation between elevated levels of these proteins and poorer performance on the online cognitive tests. This suggests the tests can work together to highlight individuals who might benefit from further assessment. Researchers emphasize this isn’t a diagnostic tool. Instead, it’s a screening method to identify those who should be referred for more comprehensive evaluation.
The potential benefits of early detection are significant. While there's no cure for most forms of dementia, early interventions can help manage symptoms. These interventions include lifestyle adjustments, cognitive training, and, potentially, future disease-modifying therapies. Identifying risk earlier could also allow individuals to plan for their future care.
The research team is now working to refine the tests and expand the study to a larger, more diverse population. They hope to validate the findings and determine the optimal way to implement this screening method in healthcare settings. The goal is to make early detection accessible and affordable for everyone.
Frequently Asked Questions
What does this test actually measure? The test measures the level of certain proteins in a blood sample. These proteins are indicators of changes happening in the brain that can precede the onset of dementia symptoms. Combined with cognitive tests, it offers a risk assessment.
Is this test a definitive diagnosis of dementia? No, this test is not a diagnosis. It’s a screening tool designed to identify individuals who may be at higher risk. Further, more detailed assessments are needed to confirm a dementia diagnosis.
When might this test be widely available? While promising, the test is still under development. Researchers are working to validate the results with larger studies. Widespread availability will depend on successful validation and integration into healthcare systems.